Author

Debabrata Bhattasali

Institutions: Biocon (India), Syngene International (India)

Observed institutions: Bristol-Myers Squibb (United States), Bristol-Myers Squibb (India), Biocon (India), Syngene International (India)

ORCID: 0000-0002-0707-7743

Observed ORCID: 0000-0002-0707-7743

OpenAlex ID: A5117667801

Discovery and Characterization of a First-in-Class LIV1-TLR7/8 Immunomodulatory Conjugate with Robust Myeloid Activation and Antitumor Activity

2025 · Sayumi Yamazoe, Yam Poudel, et al. · Journal of Medicinal Chemistry · 5

A Practical and Scalable Route to 6-Bromo-2,4,5-trichloropyrrolo[2,1- f ][1,2,4]triazine: Process Optimization Guided by Thermal Safety Insights

2026 · Debabrata Bhattasali, Premsai Rai Neithnadka, et al. · Organic Process Research & Development · 2

Diastereoselective Synthesis of a Medicinally Significant Cis −1,1,3‐Trisubstituted Cyclopentane Derivative through Epoxide Ring Opening

2026 · Debabrata Bhattasali, Ramasamy Duraisamy, et al. · European Journal of Organic Chemistry

Supercritical fluid chromatography for Diastereoselective resolution of Cyclopentane Diol core: a scalable approach to chiral purity

2026 · Shyamsundar Murugesan, Ratalababu Madam, et al. · Journal of Chromatography A

Works count: 4

Citation count: 7

H-index: 2

I10-index: